Our lab has shown in the past that KLK7 may serve as a potential biomarker for breast cancer patients (Talieri et al, 2004) and that its overexpression in intracranial tumours reveals a less favourable outcome (Prezas et al, 2006b). This evidence concerns the gene KLK7 and breast cancer.